Chapter 39: Antibiotics Part 2

Aminoglycosides including amikacin, gentamicin, and tobramycin function through inhibition of bacterial protein synthesis via binding to ribosomal subunits, demonstrating concentration-dependent bactericidal activity and providing a postantibiotic suppressive effect that extends their clinical utility. These agents excel against gram-negative pathogens and are frequently combined with beta-lactams for synergistic activity against gram-positive organisms, yet their nephrotoxic and ototoxic potential necessitates careful therapeutic drug monitoring and baseline auditory assessment. Fluoroquinolones such as ciprofloxacin, levofloxacin, and moxifloxacin inhibit essential bacterial enzymes responsible for deoxyribonucleic acid manipulation, enabling broad-spectrum coverage across urinary, respiratory, gastrointestinal, and dermatologic infections. However, these agents carry substantial black box warnings including tendon rupture, cardiac rhythm prolongation, neurologic complications, and metabolic disturbances that demand electrocardiographic monitoring and careful medication interaction management, particularly with cation-containing compounds that reduce absorption. The miscellaneous antimicrobial category encompasses clindamycin for anaerobic coverage with significant Clostridioides difficile risk, linezolid for multidrug-resistant gram-positive organisms with serotonin syndrome potential, vancomycin as the cornerstone agent for methicillin-resistant Staphylococcus aureus requiring serum concentration monitoring, metronidazole for anaerobic and protozoal pathogens with absolute alcohol avoidance, daptomycin for resistant gram-positive infections excluding pulmonary use, and nitrofurantoin primarily for uncomplicated urinary tract infections. Advanced reserve agents including telavancin and colistimethate address multidrug-resistant gram-negative organisms when standard therapies fail. Nursing practice emphasizes comprehensive renal and hepatic function evaluation, systematic monitoring for adverse effects including infusion reactions and sensory complications, patient education regarding medication adherence and therapeutic lifestyle modifications, and antimicrobial stewardship principles to mitigate resistance development.